B. Riley Predicts Varex Imaging's Q3 Earnings (NASDAQ:VREX)

Varex Imaging Co. (NASDAQ:VREX - Free Report) - Equities researchers at B. Riley issued their Q3 2025 EPS estimates for shares of Varex Imaging in a research note issued to investors on Monday, May 12th. B. Riley analyst A. Schock forecasts that the company will post earnings of $0.03 per share for the quarter. B. Riley currently has a "Strong-Buy" rating on the stock. The consensus estimate for Varex Imaging's current full-year earnings is $0.53 per share. B. Riley also issued estimates for Varex Imaging's Q4 2025 earnings at $0.06 EPS, FY2025 earnings at $0.41 EPS, Q2 2026 earnings at $0.10 EPS, Q4 2026 earnings at $0.24 EPS and FY2026 earnings at $0.52 EPS.

Varex Imaging (NASDAQ:VREX - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.12. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. The company had revenue of $212.90 million for the quarter, compared to the consensus estimate of $206.76 million. During the same quarter in the previous year, the company earned $0.16 EPS. Varex Imaging's quarterly revenue was up 3.3% compared to the same quarter last year.

Other research analysts also recently issued research reports about the stock. Oppenheimer lowered their price objective on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating on the stock in a report on Friday, February 7th. StockNews.com upgraded shares of Varex Imaging from a "hold" rating to a "buy" rating in a report on Friday, February 7th.

Varex Imaging Stock Down 0.3%

Varex Imaging stock opened at $7.50 on Wednesday. The company has a quick ratio of 2.50, a current ratio of 4.36 and a debt-to-equity ratio of 1.02. The firm's fifty day moving average is $9.66 and its 200 day moving average is $12.64. Varex Imaging has a 12-month low of $6.76 and a 12-month high of $16.93. The company has a market capitalization of $309 million, a PE ratio of -6.41 and a beta of 0.62.

Institutional Trading of Varex Imaging

Several institutional investors have recently made changes to their positions in VREX. Barclays PLC grew its stake in shares of Varex Imaging by 15.3% in the 3rd quarter. Barclays PLC now owns 97,883 shares of the company's stock worth $1,166,000 after acquiring an additional 12,966 shares in the last quarter. Empowered Funds LLC grew its stake in shares of Varex Imaging by 5.1% in the 4th quarter. Empowered Funds LLC now owns 166,977 shares of the company's stock worth $2,436,000 after acquiring an additional 8,104 shares in the last quarter. Savant Capital LLC bought a new stake in shares of Varex Imaging in the 4th quarter worth $237,000. Principal Financial Group Inc. grew its stake in shares of Varex Imaging by 10.5% in the 4th quarter. Principal Financial Group Inc. now owns 41,144 shares of the company's stock worth $600,000 after acquiring an additional 3,914 shares in the last quarter. Finally, Rice Hall James & Associates LLC grew its stake in shares of Varex Imaging by 240.7% in the 4th quarter. Rice Hall James & Associates LLC now owns 328,692 shares of the company's stock worth $4,796,000 after acquiring an additional 232,229 shares in the last quarter.

Insiders Place Their Bets

In other Varex Imaging news, SVP Kimberley E. Honeysett sold 4,007 shares of the company's stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total transaction of $51,329.67. Following the transaction, the senior vice president now owns 4,002 shares in the company, valued at approximately $51,265.62. This represents a 50.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Sunny Sanyal sold 8,749 shares of the company's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total transaction of $98,338.76. Following the completion of the sale, the chief executive officer now owns 190,193 shares of the company's stock, valued at approximately $2,137,769.32. The trade was a 4.40% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.30% of the company's stock.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.